pharma · Restless Legs Syndrome
Dong Jie
Dong Jie is a pharma organization headquartered in CN. Primary therapeutic focus areas include Restless Legs Syndrome. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 1
- Patents
- 0
Pramipexole
Approved · small molecule · Restless Legs Syndrome
Pramipexole for Restless Legs Syndrome is a Approved program (small_molecule) at Dong Jie with 1 ClinicalTrials.gov record(s).
Internal code pramipexole
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Dong Jie
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Restless Legs Syndrome
- Status
- terminated
- Trials
- 1